Skip to main content
AQST logo

AQST · Aquestive Therapeutics, Inc. · Holdings

Track AQST — free
$4.05 +0.22 (+5.74%)
Market Cap
$512.80M
Shares
125.51M
Volume · Oct 20 2.25M Avg daily vol (3M) 2.77M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Institutional holdings are being reconciled with SEC filings. Holder totals and changes may be incomplete until reconciliation finishes.
The Sep 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out. Each fund's Change is measured against its own previous reported quarter, shown in the Reported column. Pick a completed quarter in the Quarter selector below to put every fund on one quarter and see the stock-wide activity breakdown.
Holders: 185
Total Value: $304,382,640
Total Shares: 73,076,582
Showing 1–100 of 192 holdings by value · page 1 of 2

Institutional Ownership Trend

27 quarters

Holder Concentration

Across 186 13F filers
Top Holder
13.3%
Sep 2023 → Jun 2026 · range 13.0% – 40.9%
of institutional value
Top 5
44.7%
Sep 2023 → Jun 2026 · range 43.0% – 74.0%
of institutional value
Top 10
59.9%
Sep 2023 → Jun 2026 · range 57.8% – 84.7%
of institutional value
HHI
543
Sep 2023 → Jun 2026 · range 504 – 2,082
Broadly held

Who Holds AQST

Last 8 quarters through Sep 30, 2026 (filing window open)

Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book. The quarter selector does not change this card.

Jun 30, 2026, the newest closed quarter: 184 filers, like-for-like change +0.2%; actively managed books -3.2%; index-like books +6.7%.

Holder type Share Filers Change
Registered adviser 42.1% 103 +0.1%
Exempt adviser 0.4% 1 +530.5%
Adviser 9.4% 5 -8.7%
Bank 12.0% 15 +2.5%
Insurer 0.0% 1 +9.5%
Broker-dealer 0.1% 1 +0.3%
Benefit plan 0.3% 2 -25.7%
Non-US 1.3% 4 +1.8%
Holding company 13.3% 6 -3.6%
Unknown 21.1% 46 +4.6%

The Sep 30, 2026 filing window is still open, so its bar carries the Jun 30, 2026 positions of filers that have not filed yet.

How the mix is measured

Shares are 13F common shares restated to today's split basis; options and principal amounts are left out. The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none was. Actively managed books are those measured systematic-like, concentrated or diversified active.

Excluded 2 holders with no observed 2026-03-31 13F and 1 holder with no observed 2026-06-30 13F.

Conviction and Crowding

184 13F filers, quarter ended Jun 30, 2026

Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts filers with high turnover or that advise private funds on Form ADV.

Conviction holders
3
1.63% of filers hold it in their top 10
Mar 31, 2026: 2
Holders above 5%
1
median weight 0.001%
Mar 31, 2026: 1
Crowding
18.7%
of shares outstanding, 55th percentile
Mar 31, 2026: 20.2%
Private-fund advisers
16.5%
of shares outstanding
Institutional ownership
57.4%
58.9% of the estimated free float
Top 10 holders
61.4%
of 13F shares, Herfindahl 0.057
Active holders
-3.2%
like-for-like share change of active filers
5% stakes on record
3
0 13D, 3 13G (2 institutional, 0 passive, 1 exempt)
How long holders have held it value-weighted 10.8 quarters
Under 1 year 19.2% 1 to 3 years 52.3% 3 years or more 28.5% Since coverage start 0.000%

Managers in the top fifth by current three-year FundScore alpha were net buyers of $0 (0 buying, 0 selling).

Estimated Holder Cost Basis

Quarter ended Jun 30, 2026, on that quarter's share basis

Estimated, never filed: each 13F buy is costed at its quarter's average traded price and each sale keeps the average cost, so this is what holders paid on average if they traded evenly through each quarter.

Estimated avg cost
$4.31
estimated per share
Mar 31, 2026: $4.33
Quarter-end price
$4.16
implied by 13F values
Estimated gain or loss
-3.5%
price against the estimated cost
Estimated at a loss
64.5%
of costed 13F value

Estimated cost covers 53.2% of the 13F shares; positions already held when a filer's 13F history starts, or bought in a quarter without a trusted average price, have no estimate.

Shared Holders

Companies AQST's active holders also own, quarter ended Jun 30, 2026
# Company Shared holders
1 ARTV Artiva Biotherapeutics, Inc. 5
2 OBIO Orchestra BioMed Holdings, Inc. 4
3 EYPT EyePoint, Inc. 5
4 DCTH Delcath Systems, Inc. 3
5 MIST Milestone Pharmaceuticals Inc. 4
6 FENC Fennec Pharmaceuticals Inc. 3
7 HELP Helus Pharma Inc. 4
8 UPB Upstream Bio, Inc. 3
9 NGNE Neurogene Inc. 3
10 LRMR Larimar Therapeutics, Inc. 3

Shareholder Targets

13F filers that own its peers but not AQST, quarter ended Jun 30, 2026

Found through its holder-overlap peers: ARTV, OBIO, EYPT, DCTH, MIST, FENC, HELP, UPB, NGNE, LRMR, CMPS, ABEO, SABS, OVID, PROF, SGMT, ALLO, RNA, CLDX, MAZE. 629 filers in all.

# Filer In peers
1 Deep Track Capital, LP Adviser, Diversified active $392,830,834 3 held
2 RA CAPITAL MANAGEMENT, L.P. Registered adviser, Concentrated $219,583,180 3 held
3 Jupiter Topco LLC Unknown, Diversified active $212,710,344 5 held
4 Kynam Capital Management, LP Registered adviser, Concentrated $198,065,406 1 held
5 Frazier Life Sciences Management, L.P. Registered adviser, Concentrated $196,871,252 2 held
6 Logos Global Management LP Registered adviser, Diversified active $172,676,400 4 held
7 ADAGE CAPITAL PARTNERS GP, L.L.C. Registered adviser, Diversified active $143,816,571 7 held
8 MILLENNIUM MANAGEMENT LLC Registered adviser, Systematic-like $136,103,461 16 held
9 TRV GP IV, LLC Unknown, Unknown $133,502,906 1 held
10 Commodore Capital LP Registered adviser, Concentrated $127,206,500 3 held

Fund Ownership of AQST by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 11.00% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 2.75% 3,456,177
Index ETFs 8.25% 10,353,679
Active ETFs 0.43% 544,770
Active funds 2.36% 2,967,593
Unclassified 1.50% 1,876,729
All registered funds 15.30% 19,198,948
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Showing 100 of 192
Export CSV
Holder Value (USD) % of 13F Shares Open

Showing the top 100 of 192 holders. Create a free account to see every holder, past quarters, search, filters and CSV export.

Key facts CIK 1398733 CUSIP 03843E104 13F (30d) 14 filings 14 filers Visit website Investor relations